The PGY2 pharmacy residency in infectious diseases is designed to transition PGY1 residency graduates from generalist practice to specialized practice focused on the care of patients with infectious diseases. Residency graduates are equipped to participate as integral members of interdisciplinary teams caring for patients with infectious diseases, assuming responsibility for their pharmaceutical care, and function as a member of an IDSA-designated Antimicrobial Stewardship Center of Excellence and system-wide stewardship program. They are also trained to provide this care as an independent practitioner. The wealth of residency graduates’ knowledge of infectious diseases and their treatment with the anti-infectives class of medications combined with extensive care of individuals with an infectious disease produces a pharmacist who can successfully serve health care organizations as the ultimate resource for information about anti-infectives and for decision-making affecting the care of these patients - including leadership in formulary decision-making for anti-infectives. The care of the immunocompromised host (solid-organ transplant, bone marrow transplant, heme/onc, and the critically ill) is heavily emphasized in this program.
Exiting residents have been trained to assume responsibility for identifying and implementing opportunities to improve the medication-use system in the infectious diseases practice area, whether that practice is with a university-type teaching service or in collaboration with private or solo practitioners.
Groomed for practice leadership, infectious diseases pharmacy residency graduates can be expected to continue their pursuit of expertise in practice; to possess advanced skills to identify the pharmacotherapy and medication-use training needs of other health care professionals caring for individuals with infectious diseases; to deliver effective training to those health professionals; and to contribute to public health efforts for health improvement, wellness, and the prevention of infectious diseases. In this public health role they are trained to initiate and monitor efforts to reduce the spread of antibiotic resistance and vaccine preventable diseases.
Positions available: 1
Duration: 12 months, beginning early July
Application deadline: January 5th
Submit all application materials through PhORCAS
On-site interview required
Required participation in the ASHP National Matching Program
NMS Program Code: 637455
Licensure and employment: Texas pharmacist licensure is required within 90 days of starting the program. Failure to do so will result in termination of employment.
Houston Methodist is committed to improving the health of our patients, employees and community. As a health care provider, it is our responsibility to promote a healthier environment for our employees. Accordingly, effective January 1, 2013, Houston Methodist no longer hires tobacco users. Applicants will be tested for tobacco usage during the post-offer physical and drug screening. If an applicant tests positive for tobacco use or recreational drug use, the offer will be rescinded.
Core rotations: Adult general infectious diseases consult, Immunocompromised ID consult, Microbiology lab, Bone Marrow Transplant, Solid Organ Transplant, Infection Control and Quality (longitudinal), Antimicrobial Stewardship (longitudinal)
Elective rotations: Research/Project Management, Surgical ICU/Critical Care, Wide variety of HMH PGY1 or PGY2 standing rotations, Off-site opportunities in Antimicrobial Stewardship or ID Consult
HMH Antimicrobial Stewardship Program
The HMH Antimicrobial Stewardship Program is a multidisciplinary collaboration spearheaded by the Departments of Pharmacy and Pathology & Genomic Medicine with support from the infectious diseases medical staff, infection control, IT, and hospital leadership. We integrate real-time clinical intervention, rapid molecular diagnostics, and decision support tools to positively impact patient care. HMH is an IDSA-designated Antimicrobial Stewardship Center of Excellence.
Houston Methodist Hospital (HMH) is located in the heart of the world renowned Texas Medical Center. Offering many opportunities for clinical and didactic teaching, it is a teaching affiliate for several top ranked universities and colleges of pharmacy. U.S. News & World Report ranked Houston Methodist Hospital in 9 specialties nationally and the No. 1 hospital in Texas and Gulf Coast. Houston Methodist highly performs in nine of nine common conditions and procedures evaluated by U.S. News & World Report. Additionally, HMH is included on Forbes magazine's list of "America's Best Employers". For more information, visit www.methodistpharmacy.org